Zobrazeno 1 - 10
of 141
pro vyhledávání: '"Kluetz PG"'
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S37-S37
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S37-S37
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Clinical Positron Imaging July-August 2000 3(4):174-174
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fallah J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Heiss BL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Joeng HK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Weinstock C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gao X; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pierce WF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Chukwurah B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Bhatnagar V; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Fiero MH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Suzman DL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Nov 15; Vol. 30 (22), pp. 5003-5008.
Autor:
Fallah J; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Mulkey F; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Fiero MH; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Gittleman H; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Song C; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Puthiamadathil J; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Amatya A; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Agrawal S; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Vellanki P; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Suzman DL; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Singh H; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD.; Oncology Center of Excellence (OCE), US Food and Drug Administration, Silver Spring, MD., Amiri-Kordestani L; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD.; Oncology Center of Excellence (OCE), US Food and Drug Administration, Silver Spring, MD., Mishra-Kalyani P; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD., Pazdur R; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD.; Oncology Center of Excellence (OCE), US Food and Drug Administration, Silver Spring, MD., Kluetz PG; Center for Drug Evaluation and Research (CDER), US Food and Drug Administration, Silver Spring, MD.; Oncology Center of Excellence (OCE), US Food and Drug Administration, Silver Spring, MD.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Nov 10; Vol. 42 (32), pp. 3783-3787. Date of Electronic Publication: 2024 Sep 17.
Autor:
Rivera DR; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Eckert JC; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Rodriguez-Watson C; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Lerro CC; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Bertagnolli MM; Alliance for Clinical Trials in Oncology, Brigham & Women's Hospital, Boston, Massachusetts, USA., Hubbard RA; Department of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Lund JL; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Schrag D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Wang SV; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Wood WA; Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Lee JJ; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Okafor C; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Ghauri K; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Winckler SC; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Kluetz PG; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Nov; Vol. 33 (11), pp. e5818.
Autor:
Brave MH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Maguire WF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Weinstock C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Zhang H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gao X; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Li F; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Yu J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Fu W; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Zhao H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pierce WF; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chang E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Dinin J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Fiero MH; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Rahman NA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Tang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Kluetz PG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Suzman DL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Nov 01; Vol. 30 (21), pp. 4815-4821.
Autor:
Agrawal S; United States Food and Drug Administration, Silver Spring, MD, United States., Lee C; United States Food and Drug Administration, Silver Spring, Maryland, United States., Pierce WF; Food and Drug Administration, Silver Spring, Maryland, United States., Everhart E; United States Food and Drug Administration, Silver Spring, MD, United States., King-Ducre A; Food and Drug Administration, Silver Spring, Maryland, United States., Royce M; United States Food and Drug Administration, Silver Spring, Maryland, United States., Osgood CL; United States Food and Drug Administration, Silver Spring, MD, United States., Amiri-Kordestani L; Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, United States., Chiu HJ; Food and Drug Administration, Silver Spring, Maryland, United States., Ricks TK; United States Food and Drug Administration, Silver Spring, MD, United States., Pan L; United States Food and Drug Administration, Silver Spring, Maryland, United States., Fourie Zirkelbach J; United States Food and Drug Administration, Silver Spring, Maryland, United States., Charlab R; United States Food and Drug Administration, Silver Spring, MD, United States., Pacanowski M; United States Food and Drug Administration, Silver Spring, MD, United States., Kim T; United States Food and Drug Administration, Silver Spring, MD, United States., Pazdur R; United States Food and Drug Administration, Silver Spring, MD, United States., Kluetz PG; Food and Drug Administration, Silver Spring, MD, United States., Gao JJ; United States Food and Drug Administration, Silver Spring, MD, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.